LifeMD, Inc. SEC filings LFMD

LifeMD, Inc. has 578 filings in SEC EDGAR's recent list, going back to May 17, 2012. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

LifeMD, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2026 —
S-8 Employee stock plan registration Sep 25, 2026 —
8-K Current report
Regulation FD disclosure
Sep 15, 2026 Sep 15, 2026
4 Insider transaction Aug 18, 2026 Aug 11, 2026
4 Insider transaction Aug 18, 2026 May 4, 2026
4 Insider transaction Aug 13, 2026 Aug 11, 2026
4/A Form 4/a Aug 13, 2026 Dec 2, 2024
4 Insider transaction Aug 13, 2026 May 4, 2026
4 Insider transaction Aug 13, 2026 Aug 11, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2026 Aug 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 8, 2026 —
8-K Current report
Regulation FD disclosure
Jun 22, 2026 Jun 22, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
3 Initial insider ownership Jun 3, 2026 Jun 1, 2026
4 Insider transaction May 13, 2026 May 11, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
4 Insider transaction Apr 1, 2026 Mar 30, 2026
3 Initial insider ownership Apr 1, 2026 Mar 16, 2026
3 Initial insider ownership Apr 1, 2026 Mar 16, 2026
S-8 Employee stock plan registration Apr 1, 2026 —
144 Notice of proposed sale Mar 23, 2026 —
8-K Current report
Officer or director change, Other events
Mar 18, 2026 Mar 16, 2026
10-K Annual report Mar 10, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 9, 2026 Mar 9, 2026
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Jan 6, 2026 Jan 2, 2026
4 Insider transaction Dec 11, 2025 Dec 9, 2025
144 Notice of proposed sale Nov 24, 2025 —
10-Q Quarterly report Nov 17, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 17, 2025 Nov 17, 2025
NT 10-Q Filing Nov 12, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Nov 5, 2025 Nov 5, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Nov 4, 2025 Nov 4, 2025
4 Insider transaction Oct 8, 2025 Oct 6, 2025
4 Insider transaction Oct 8, 2025 Oct 6, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Sep 12, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 10, 2025 —
4 Insider transaction Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
8-K Current report
Auditor change
Aug 21, 2025 Aug 15, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
144 Notice of proposed sale Aug 1, 2025 —
4 Insider transaction Jul 31, 2025 Jul 27, 2025
3 Initial insider ownership Jul 31, 2025 Jul 22, 2025
8-K Current report
Officer or director change, Other events
Jul 31, 2025 Jul 31, 2025
4 Insider transaction Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
8-K Current report
Shareholder vote results
Jun 16, 2025 Jun 13, 2025
144 Notice of proposed sale Jun 13, 2025 —
4 Insider transaction Jun 4, 2025 Jun 2, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
144 Notice of proposed sale Apr 29, 2025 —
8-K Current report
Regulation FD disclosure
Apr 29, 2025 Apr 25, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Apr 28, 2025
8-K Current report
Auditor change
Apr 25, 2025 Apr 24, 2025
4 Insider transaction Apr 3, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Mar 20, 2025 Mar 19, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 11, 2025 Mar 6, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
10-K Annual report Mar 11, 2025 Dec 31, 2024
4 Insider transaction Mar 10, 2025 Mar 6, 2025
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
3 Initial insider ownership Feb 26, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 14, 2025
UPLOAD Letter from the SEC Feb 14, 2025 —
CORRESP Letter to the SEC Jan 31, 2025 —
UPLOAD Letter from the SEC Jan 17, 2025 —
S-8 Employee stock plan registration Jan 13, 2025 —
4 Insider transaction Jan 6, 2025 Jan 2, 2025
8-K Current report
Officer or director change
Dec 31, 2024 Dec 24, 2024
4 Insider transaction Dec 26, 2024 Dec 20, 2024
8-K Current report
Officer or director change
Dec 23, 2024 Dec 18, 2024
CORRESP Letter to the SEC Dec 12, 2024 —
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Dec 5, 2024 Dec 2, 2024
4 Insider transaction Dec 5, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
144 Notice of proposed sale Dec 2, 2024 —
UPLOAD Letter from the SEC Nov 22, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Oct 31, 2024 Oct 25, 2024
CORRESP Letter to the SEC Oct 25, 2024 —
SC 13G Ownership over 5% (passive) Oct 24, 2024 —
UPLOAD Letter from the SEC Oct 16, 2024 —
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Aug 20, 2024 Apr 4, 2022
424B3 Prospectus Aug 13, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
4 Insider transaction Jul 19, 2024 Jul 17, 2024
EFFECT Filing Jul 18, 2024 —
EFFECT Filing Jul 18, 2024 —
CORRESP Letter to the SEC Jul 16, 2024 —
CORRESP Letter to the SEC Jul 16, 2024 —
S-3/A Filing Jul 5, 2024 —
S-3/A Filing Jul 5, 2024 —
S-8 Employee stock plan registration Jul 5, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2024 Jun 14, 2024
UPLOAD Letter from the SEC Jun 17, 2024 —
UPLOAD Letter from the SEC Jun 10, 2024 —
S-3 Shelf registration Jun 7, 2024 —
S-3 Shelf registration May 31, 2024 —
DEFR14A Filing May 24, 2024 —
4 Insider transaction May 20, 2024 Apr 26, 2024
3 Initial insider ownership May 20, 2024 Apr 26, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Officer or director change, Other events
May 2, 2024 Apr 26, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Dec 31, 2023
4 Insider transaction Apr 5, 2024 Apr 4, 2024
4 Insider transaction Mar 25, 2024 Mar 21, 2024
4 Insider transaction Mar 25, 2024 Mar 21, 2024
4 Insider transaction Mar 25, 2024 Mar 21, 2024
4 Insider transaction Mar 25, 2024 Mar 21, 2024
4 Insider transaction Mar 25, 2024 Mar 21, 2024
S-8 Employee stock plan registration Mar 15, 2024 —
4 Insider transaction Mar 14, 2024 Mar 13, 2024
10-K Annual report Mar 11, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
S-8 Employee stock plan registration Dec 21, 2023 —
8-K Current report
Unregistered share sale, Regulation FD disclosure, Other events
Dec 13, 2023 Dec 11, 2023
4 Insider transaction Nov 15, 2023 Nov 13, 2023
8-K Current report
Officer or director change
Nov 14, 2023 Nov 8, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
4 Insider transaction Nov 8, 2023 Nov 6, 2023
SC 13G Ownership over 5% (passive) Oct 6, 2023 —
4/A Primary document Sep 1, 2023 Jun 7, 2023
4 Insider transaction Aug 31, 2023 Nov 2, 2022
4 Insider transaction Aug 29, 2023 Sep 7, 2021
4 Insider transaction Aug 23, 2023 Aug 21, 2023
8-K Current report
Regulation FD disclosure
Aug 10, 2023 Aug 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
4 Insider transaction Aug 1, 2023 Jan 27, 2022
8-K Current report
Officer or director change
Jul 31, 2023 Jul 28, 2023
8-K Current report
Officer or director change
Jul 14, 2023 Jul 11, 2023
4 Insider transaction Jul 13, 2023 Jul 12, 2023
4 Insider transaction Jul 13, 2023 Jan 27, 2023
8-K Current report
Shareholder vote results
Jul 7, 2023 Jun 16, 2023
424B5 Prospectus supplement Jun 29, 2023 —
4 Insider transaction Jun 22, 2023 Jun 20, 2023
8-K Current report
Officer or director change, Other events
Jun 22, 2023 Jun 20, 2023
3 Initial insider ownership Jun 22, 2023 Jun 20, 2023
8-K Current report
Officer or director change
Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 16, 2023 Jun 15, 2023
4 Insider transaction Jun 16, 2023 Jun 14, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 14, 2023 Jun 7, 2023
4 Insider transaction Jun 14, 2023 Jun 13, 2023
4 Insider transaction Jun 7, 2023 Jun 5, 2023
4/A Primary document May 31, 2023 May 23, 2023
4 Insider transaction May 30, 2023 May 26, 2023
4 Insider transaction May 24, 2023 May 22, 2023
4 Insider transaction May 23, 2023 May 23, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Apr 28, 2023
424B5 Prospectus supplement Mar 27, 2023 —
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Mar 23, 2023 Mar 21, 2023
10-K Annual report Mar 22, 2023 Dec 31, 2022
4 Insider transaction Feb 13, 2023 Feb 9, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
LFMD (Nasdaq), LFMDP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Accelerated filer
SEC CIK
948320
Former names
CONVERSION LABS, INC. (until Feb 22, 2021); Immudyne, Inc. (until Jun 19, 2018)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.